Leerink Partnrs Issues Optimistic Outlook for EHC Earnings

Encompass Health Co. (NYSE:EHC) – Stock analysts at Leerink Partnrs boosted their Q2 2025 earnings estimates for Encompass Health in a research report issued on Wednesday, April 30th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $1.31 per share for the quarter, up from their prior forecast of $1.18. The consensus estimate for Encompass Health’s current full-year earnings is $4.80 per share. Leerink Partnrs also issued estimates for Encompass Health’s Q3 2025 earnings at $1.11 EPS, Q4 2025 earnings at $1.17 EPS, Q1 2026 earnings at $1.56 EPS, FY2026 earnings at $5.51 EPS, FY2027 earnings at $5.73 EPS and FY2028 earnings at $5.95 EPS.

A number of other analysts have also recently weighed in on EHC. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays lifted their price target on Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a report on Friday, April 25th. Royal Bank of Canada increased their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a report on Monday, April 28th. UBS Group lifted their target price on Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a research note on Monday, April 28th. Finally, Truist Financial reissued a “buy” rating and issued a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Encompass Health presently has an average rating of “Buy” and an average target price of $120.86.

Encompass Health Stock Up 0.6 %

Shares of Encompass Health stock opened at $117.02 on Monday. Encompass Health has a twelve month low of $82.74 and a twelve month high of $117.98. The stock has a market capitalization of $11.78 billion, a price-to-earnings ratio of 26.24, a PEG ratio of 2.31 and a beta of 0.91. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The business’s 50 day simple moving average is $102.40 and its 200-day simple moving average is $99.52.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the firm earned $1.12 EPS. The company’s revenue for the quarter was up 10.6% compared to the same quarter last year.

Institutional Investors Weigh In On Encompass Health

Several hedge funds have recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB lifted its position in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Colonial Trust Co SC acquired a new stake in shares of Encompass Health during the 4th quarter valued at $29,000. Transce3nd LLC purchased a new position in shares of Encompass Health during the 4th quarter valued at $40,000. CBIZ Investment Advisory Services LLC increased its stake in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after acquiring an additional 127 shares during the last quarter. Finally, Tompkins Financial Corp purchased a new stake in shares of Encompass Health during the fourth quarter worth $46,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now owns 79,710 shares of the company’s stock, valued at approximately $9,149,910.90. This trade represents a 11.15 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health’s payout ratio is currently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.